Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by GlobeNewswire
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
99
100
Next >
REPLIMUNE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Replimune Group, Inc. and Encourages Investors to Contact the Firm Before September 22nd
September 11, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Tickers
REPL
Gildan Announces Participation at the 29th Annual Scotiabank Back to School Conference in Toronto
September 11, 2025
From
Gildan Activewear
Via
GlobeNewswire
Tickers
GIL
TSX:GIL
Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units
September 11, 2025
From
Cosmos Health Inc.
Via
GlobeNewswire
Tickers
COSM
SEGG Media Highlights Concerts.com and TicketStub.com Assets as Ticketing Market Surges Following StubHub's IPO Announcement Targeting a $9.2 Billion Valuation
September 11, 2025
From
SEGG Media Corporation
Via
GlobeNewswire
Tickers
LTRYW
Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant
September 11, 2025
From
Smith & Nephew UK Ltd
Via
GlobeNewswire
Tickers
SNN
Biodesix Announces One-for-Twenty Reverse Stock Split
September 11, 2025
From
Biodesix, Inc.
Via
GlobeNewswire
Tickers
BDSX
Elemica and Agilis Launch the Chemical Industry’s First Integrated Solution for Digital Commerce and Orchestrated Supply Chain Execution
September 11, 2025
From
Elemica
Via
GlobeNewswire
Philips and Masimo announce innovation partnership to advance access to patient monitoring measurement technologies
September 11, 2025
From
Royal Philips
Via
GlobeNewswire
Tickers
PHG
Wearable Devices Announces Pricing of $4 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
September 11, 2025
From
Wearable Devices Ltd.
Via
GlobeNewswire
Tickers
WLDS
WLDSW
RXSIGHT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against RxSight, Inc. and Encourages Investors to Contact the Firm Before September 22nd
September 11, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Tickers
RXST
TransUnion Analysis Identifies Four Distinct Consumer Groups Based on Their Ability to Keep Up with Inflation
September 11, 2025
From
TransUnion
Via
GlobeNewswire
Tickers
TRU
GCL Subsidiary 4Divinity Sign a Memorandum of Understanding to Acquire 60% Stake in Taiwan’s Alliance-Star International via Share Swap
September 11, 2025
From
GCL Global Holdings Ltd.
Via
GlobeNewswire
Tickers
GCL
GCLWW
Enlivex CEO Issues Letter to Shareholders Outlining Strategic Roadmap Following Positive Phase IIa Allocetra™ Results
September 11, 2025
From
Enlivex Therapeutics Ltd
Via
GlobeNewswire
Tickers
ENLV
Rezolve Ai Launches Visual Search, Replacing Keyword Search with Conversational Commerce
September 11, 2025
From
Rezolve AI Ltd
Via
GlobeNewswire
Tickers
RZLV
Global Mofy AI Launches New Website Domain to Strengthen Global AI Brand Identity
September 11, 2025
From
GLOBAL MOFY AI LIMITED
Via
GlobeNewswire
Tickers
GMM
authID and MajorKey Technologies Forge Strategic Alliance to Deliver High-Assurance Identity Verification for Microsoft Entra Customers
September 11, 2025
From
authID Inc.
Via
GlobeNewswire
Tickers
AUID
Amneal Receives U.S. FDA Approval of Sodium Oxybate Oral Solution
September 11, 2025
From
Amneal Pharmaceuticals LLC
Via
GlobeNewswire
Tickers
AMRX
iAnthus Expands Florida Footprint with GrowHealthy Dispensary Opening in Tamarac
September 11, 2025
From
iAnthus Capital Holdings, Inc.
Via
GlobeNewswire
Tickers
CSE:IAN
ITHUF
Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD
September 11, 2025
From
Absci Corporation; Oracle; AMD
Via
GlobeNewswire
Tickers
ABSI
AMD
ORCL
Rectitude Reports Green-Energy Progress Ten Months After Launch of AIMS System
September 11, 2025
From
Rectitude Holdings Ltd.
Via
GlobeNewswire
Tickers
RECT
Kyowa Kirin Announces Late-Breaking Abstract Presentation at the European Academy of Dermatology and Venerology Congress
September 11, 2025
From
Kyowa Kirin
Via
GlobeNewswire
Glucotrack to Participate in the Q3 Virtual Investor Summit
September 11, 2025
From
Glucotrack, Inc.
Via
GlobeNewswire
Tickers
GCTK
LINEAGE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Lineage, Inc. and Encourages Investors to Contact the Firm
September 11, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Tickers
LINE
ALTO NEUROSCIENCE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Alto Neuroscience, Inc. (ANRO) and Encourages Investors to Contact the Firm
September 11, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Tickers
ANRO
NEOGEN DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Neogen Corporation and Encourages Investors to Contact the Firm Before September 16th
September 11, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Tickers
NEOG
CAPRICOR DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors in Capricor Therapeutics, Inc. of the September 15th Deadline for the Class Action Lawsuit
September 11, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Tickers
CAPR
Prof. Ahmad AbuSalah: KFSHRC’s Sustainable Digital Innovation Ecosystem Features 30+ AI Solutions and 5 New Agents in 2025
September 11, 2025
From
King Faisal Specialist Hospital & Research Centre
Via
GlobeNewswire
BIOHAVEN FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Biohaven Investors of the September 12th Deadline to File in the Class Action Lawsuit
September 11, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Tickers
BHVN
Maze Therapeutics Announces Oversubscribed $150.0 Million Private Placement
September 11, 2025
From
Maze Therapeutics, Inc.
Via
GlobeNewswire
Tickers
MAZE
Apogee Therapeutics Announces Late-Breaker Presentation of 16-Week Data from Phase 2 APEX Trial of APG777 for Moderate-to-Severe Atopic Dermatitis at the Upcoming European Academy of Dermatology and Venereology (EADV) 2025 Congress
September 11, 2025
From
Apogee Therapeutics
Via
GlobeNewswire
Tickers
APGE
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.